Articles

Forget the Social Security crisis. Medicare funding could be a much bigger problem.

Your healthcare is still on the line, even if Medicare Part A’s funding will be depleted five years later than expected.

Here’s why Rivian is still a ‘show-me story’

Rivian Automotive Inc.’s stock may regain investor interest if the electric-vehicle maker achieves a measure of profitability later this year, but for now most Wall Street analysts remain on the sidelines.

Stocks and bonds haven’t been this in sync in decades: why both still deserve space in your portfolio

The notion that stocks should rise while bond prices fall, and vice versa, is an enduring piece of investing conventional wisdom. But history shows the relationship between the two asset classes is more complicated.

Icahn Enterprises says it will keep paying its $1 quarterly dividend

Carl Icahn’s investing arm narrowed its loss in the first quarter even as revenue fell.

Snap takes advantage of recent stock surge to sell convertible debt

Snap’s stock pulled back Wednesday after the parent of the video-messaging app Snapchat planned to take advantage of the recent runup in its stock price to sell convertible debt.

Wholesale inventories fall in March

The depletion of private inventories subtracted from the U.S. GDP in the first quarter.

Home builders’ stocks have soared since we said they were cheap. These five are expected to grow profits rapidly through 2025.

Demand for new homes has been strong, despite high mortgage-loan rates.

Intel’s stock drops after U.S. revokes licenses for exports to China customer

Intel’s stock took a hit Wednesday after the semiconductor giant disclosed that a U.S. government ruling will stop the export of some of the company’s products to a customer in China.

Reddit’s first post-IPO results are ‘mission accomplished,’ with international and data-licensing opportunities ahead

Reddit Inc.’s first quarterly results as a public company sent the company’s stock surging on better-than-expected revenue and a narrower-than-expected loss. Analysts say there are international and new data-licensing opportunities ahead for the social-media platform.

Monster Beverage launches $3 billion stock buyback

Beverage company’s chief executive may sell up to about $33 million of stock to provide “flexibility.”

Teva Pharmaceutical’s stock climbs as schizophrenia treatment shows promise

Teva Pharmaceutical Industries stock jumped more than 6% early Wednesday after the company reported first-quarter sales that topped estimates and released positive late-stage trial data on a schizophrenia treatment.

Tripadvisor’s stock could see record plunge as potential buyout plans dropped

Tripadvisor’s stock took a dive premarket Wednesday, after the online travel-booking company said it decided pursuing a potential sale would not be in the best interest of the company or its shareholders.
1 1,368 1,369 1,370 1,371 1,372 2,499